SCHEMBL10993100

SCHEMBL10993100

Cc1ccc(Oc2ccc(Oc3ccc(Oc4ccc(C)c(C)c4)cc3)cc2)cc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.60
GFER P55789 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
LMNA P02545 1/20 0.60
SMN1; SMN2 Q16637 4/20 0.58
MAPT P10636 3/20 0.58
MEN1 O00255 2/20 0.58
HPGD P15428 1/20 0.58
HAO1 Q9UJM8 1/20 0.52
HTR2A P28223 5/20 0.47
SLC6A4 P31645 5/20 0.47
TDP1 Q9NUW8 4/20 0.47
ALDH1A1 P00352 5/20 0.44
KCNH2 Q12809 4/20 0.43
TEAD4 Q15561 1/20 0.42
POLB P06746 1/20 0.41
MITF O75030 1/20 0.41
GAA P10253 1/20 0.41
NLRP1 Q9C000 1/20 0.41
NOD2 Q9HC29 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47864 1.00 KMT2A (0.60) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL47874 0.97 KMT2A (0.57) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL10984775 0.93 KMT2A (0.55) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL10259158 0.93 SMN1; SMN2 (0.62) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL10990207 0.93 KMT2A (0.55) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL257610 0.93 KMT2A (0.55) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL6438319 0.91 LTA4H (0.54) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL30358264 0.91 LTA4H (0.55) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL10007534 0.91 LTA4H (0.55) KMT2AGFERL3MBTL1LMNASMN1; SMN2
SCHEMBL4454151 0.91 LTA4H (0.55) KMT2AGFERL3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319410-B2 Precursor for polyimide and use thereof ETERNAL MATERIALS CO., LTD. (TW) 2022-05-03 US disclosed
US-11034797-B2 Polyimide precursor composition, use thereof and polyimide made therefrom ETERNAL MATERIALS CO., LTD. (TW) 2021-06-15 US disclosed
US-20210079161-A1 POLYIMIDE PRECURSOR COMPOSITION, USE THEREOF AND POLYIMIDE MADE THEREFROM ETERNAL MATERIALS CO., LTD. (TW) 2021-03-18 US disclosed
US-10731004-B2 Polyimide precursor composition and use thereof ETERNAL MATERIALS CO., LTD. (TW) 2020-08-04 US disclosed
US-10696793-B2 Process for preparing polyimides ETERNAL MATERIALS CO., LTD. (TW) 2020-06-30 US disclosed
US-10639876-B2 Solvent-containing dry film and method for applying the same on a substrate ETERNAL MATERIALS CO., LTD. (TW) 2020-05-05 US disclosed
US-10626220-B2 Precursor for polyimide and use thereof ETERNAL MATERIALS CO., LTD. (TW) 2020-04-21 US disclosed
US-20200055986-A1 PROCESS FOR PREPARING POLYIMIDES ETERNAL MATERIALS CO., LTD. (TW) 2020-02-20 US disclosed
US-10280334-B2 Polyimides, coating composition formed therefrom and use thereof ETERNAL MATERIALS CO., LTD. (TW) 2019-05-07 US disclosed
US-20180194899-A1 PRECURSOR FOR POLYIMIDE AND USE THEREOF ETERNAL MATERIALS CO., LTD. (TW) 2018-07-12 US disclosed
US-20140275440-A1 DIAMINE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF UNIMICRON TECHNOLOGY CORP. (TW) 2014-09-18 US disclosed
US-20140275440-A1 DIAMINE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF UNIMICRON TECHNOLOGY CORP. (TW) 2014-09-18 US disclosed
US-20140228512-A1 POLYIMIDES, COATING COMPOSITION FORMED THEREFROM AND USE THEREOF ETERNAL CHEMICAL CO., LTD. (TW) 2014-08-14 US disclosed
US-20140228512-A1 POLYIMIDES, COATING COMPOSITION FORMED THEREFROM AND USE THEREOF ETERNAL CHEMICAL CO., LTD. (TW) 2014-08-14 US disclosed
US-20130172494-A1 POLYIMIDE PRECURSOR COMPOSITION AND PREPARATION METHOD AND USE THEREOF ETERNAL CHEMICAL CO., LTD. (TW) 2013-07-04 US disclosed
US-20130172569-A1 BASE GENERATOR ETERNAL CHEMICAL CO., LTD. (TW) 2013-07-04 US disclosed
US-20130172569-A1 BASE GENERATOR ETERNAL CHEMICAL CO., LTD. (TW) 2013-07-04 US disclosed
US-7683152-B2 Partial block polyimide-polysiloxane copolymer, making method, and resin composition comprising the copolymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-7683152-B2 Partial block polyimide-polysiloxane copolymer, making method, and resin composition comprising the copolymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-4526984-A Autoxidation of alkyl-substituted aromatic ethers THE UPJOHN COMPANY (US) 1985-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275440-A1 DIAMINE MONOMER HAVING SIDE CHAIN, POLYIMIDE COMPOUND HAVING SIDE CHAIN AND MANUFACTURING METHOD THEREOF POLL, DDC, DDT KMT2A 1008/4885GFER 1315/4885L3MBTL1 4313/4885
US-20130172569-A1 BASE GENERATOR REV1, MUS81, PADI1 KMT2A 939/4885GFER 457/4885L3MBTL1 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.